Share Facebook Twitter Email A meta-analysis indicates VEGF-inhibitors, particularly lenvatinib and axitinib, are quite successful at achieving disease control for recurrent or metastatic adenoid cystic carcinoma. | Hoff, JAMA Otolaryngol Head Neck Surg 2024 Adenoid cystic
